Solar urticaria

L12_SOLURTICARIA

photosensitivity disease: Photosensitivity refers to various symptoms, diseases and conditions caused or aggravated by exposure to sunlight.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L56.3 Cause of death: ICD-10 — L56.3 2 out of 7 registries used, show all original rules.	50
4. Check minimum number of events None	50
5. Include endpoints None	50
6. Filter based on genotype QC (FinnGen only)	48

Control definitions (FinnGen only)

Control exclude: L12_RADIATIONRELATEDSKIN

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L56
Name in latin: Urticaria solaris

NAME	L12_SOLURTICARIA
CONTROL_EXCLUDE	L12_RADIATIONRELATEDSKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L563
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L563
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Solar urticaria based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	367	234	132
Only index persons	304	203	101
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.00
Median age at first event (years)
Whole population	30.97	35.89	22.21
Only index persons	37.92	40.56	32.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	48	38	10
Unadjusted period prevalence (%)	0.01	0.01	0.00
Median age at first event (years)	47.17	42.51	64.90

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
50: Matched controls
500

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L56.3

ICD-10 Finland

Solar urticaria

+∞

71.5

L56.4

ICD-10 Finland

Polymorphous light eruption

122.2

9.8

L50.8

ICD-10 Finland

Other urticaria

46.5

7.0

D07AC01

ATC

betamethasone; topical

4.6

6.7

101

Z76.0

ICD-10 Finland

Issue of repeat prescription

4.7

6.6

XQ802

NOMESCO Finland

Epicutan test

15.2

6.4

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42529406) Shigella sp [Presence] in Stool by Culture

5.41

2.12

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

5.41

2.12

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

5.41

2.12

1.2

—

(40758558) Short blood count panel - Blood

112

2.12

1.66

11.0

6.4

—

(3025941) Bacteria identified in Stool by Culture

2.82

1.41

1.0

1.2

—

(3000492) Spirometry study

2.33

1.39

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.70

1.35

1.2

1.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

175

1.86

1.29

3.3

7.3

1.24

1.22

mmol/l

0.68

154

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.58

1.28

1.0

1.1

—

(40768443) Skin Pathology biopsy report

2.81

1.24

1.2

1.0

—

(40768804) Tissue Pathology biopsy report

181

1.76

1.11

2.3

1.7

—

(3015736) pH of Urine

176

0.52

1.07

3.1

3.2

—

5.50

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.16

1.05

1.7

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

195

1.69

0.99

6.2

6.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1.80

0.94

1.8

1.3

2.46

2.14

g/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.94

0.91

1.6

2.0

—

(3026008) Bacteria identified in Urine by Culture

132

0.53

0.90

3.9

2.4

—

(3002256) Pathology report gross observation

1.83

0.85

1.0

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

201

1.61

0.85

6.5

5.6

57.38

57.51

0.02

192

(40768797) Stomach Pathology biopsy report

1.79

0.83

1.0

1.3

—

(4035726) Immunohistochemistry procedure

1.92

0.76

1.1

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.80

0.75

1.1

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

104

1.63

0.73

1.3

—

1.79

—

(3023368) Bacteria identified in Blood by Culture

1.60

0.63

4.1

3.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

201

1.49

0.63

6.7

5.7

28.24

28.57

0.05

192

(3000764) Benzodiazepines [Presence] in Urine

0.00

0.62

0.0

1.5

—

(3016879) Cocaine [Presence] in Urine

0.00

0.62

0.0

1.4

—

(3028300) Cannabinoids [Presence] in Urine

0.00

0.61

0.0

1.4

—

(3027944) Amphetamines [Presence] in Urine

0.00

0.61

0.0

1.4

—

(3027008) Opiates [Presence] in Urine

0.00

0.61

0.0

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.87

0.61

1.8

1.6

—

(3009343) pH of Capillary blood

0.00

0.61

0.0

3.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

0.57

0.59

5.2

3.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

216

0.68

0.57

1.8

2.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

131

1.45

0.51

2.1

2.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.61

0.51

3.0

4.8

224.43

250.57

u/l

—

(3006504) Eosinophils/100 leukocytes in Blood

198

1.41

0.50

6.9

5.7

2.42

2.65

0.41

187

(3013512) EKG study

105

1.46

0.48

4.9

3.4

—

(3019069) Monocytes/100 leukocytes in Blood

200

1.38

0.46

7.0

6.0

7.75

7.72

0.02

191

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

332

1.44

0.45

2.8

3.6

—

(40761536) Microorganisms panel - Urine sediment

1.68

0.44

1.8

2.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

231

1.37

0.44

5.0

4.0

7.43

6.31

mmol/l

1.16

206

(3020682) Albumin/Creatinine [Ratio] in Urine

1.44

0.43

4.9

3.4

3.92

11.67

mg/mmol

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.42

0.0

1.2

—

(3022313) Gas panel - Capillary blood

0.00

0.42

0.0

4.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.41

0.0

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

184

1.35

0.40

2.0

2.2

80.56

72.87

nmol/l

0.63

158

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.43

0.39

1.0

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

295

1.35

0.38

4.2

3.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

163

0.73

0.37

3.0

3.2

—

(21494755) Public health laboratory ask at order entry panel

1.38

0.35

1.2

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

371

1.39

0.33

17.2

14.4

14.23

15.01

0.37

365

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

118

0.71

0.32

1.2

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1.36

0.32

3.3

2.7

15.68

58.46

mg/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.31

0.22

2.3

2.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1.31

0.22

1.3

1.6

0.61

0.71

mg/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.21

0.0

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.21

0.0

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

0.00

0.21

0.0

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

488

+∞

0.21

21.2

17.9

133.68

134.51

g/l

0.21

479

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.21

0.0

2.5

—

4.38

—

(3024731) MCV [Entitic volume]

487

+∞

0.21

21.1

17.7

90.29

90.73

0.30

479

(3026361) Erythrocytes [#/volume] in Blood

487

+∞

0.21

21.2

17.8

4.48

4.47

e12/l

0.07

476

(3035941) MCH [Entitic mass]

487

+∞

0.21

20.9

17.7

29.93

30.24

0.57

479

(3010813) Leukocytes [#/volume] in Blood

487

+∞

0.21

21.1

17.8

7.34

6.58

e9/l

1.18

476

(3007461) Platelets [#/volume] in Blood

486

+∞

0.20

21.3

17.9

269.68

258.43

e9/l

0.55

477

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.17

0.20

1.5

2.5

24.17

24.93

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

120

0.79

0.19

1.6

1.07

1.37

mmol/l

—

107

(3044640) Blood type and Crossmatch panel - Blood

140

0.81

0.18

2.3

2.1

—

(3003694) ABO and Rh group [Type] in Blood

129

0.81

0.17

1.9

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

0.76

0.16

1.0

1.9

7.17

5.22

e6/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

161

1.18

0.16

2.4

1.9

107.36

98.63

pmol/l

0.26

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

106

0.82

0.14

1.9

2.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

294

1.14

0.11

4.9

4.0

—

55.00

—

(36304419) Bacteria [Presence] in Urine

116

1.16

0.10

1.8

2.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.19

0.10

2.6

2.3

—

(3022145) Colonoscopy Study observation

1.15

0.10

1.4

1.3

—

(36660697) Celiac disease serology panel - Serum

1.12

0.10

1.2

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.08

0.09

1.5

2.5

2.42

2.41

g/l

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

216

1.12

0.09

2.7

2.8

82.16

89.78

ug/l

0.12

204

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1.17

0.09

3.3

3.5

734.10

1097.14

ng/l

—

(3042936) Bacteria identified in Isolate by Culture

0.82

0.09

2.2

2.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.79

0.09

1.2

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

0.77

0.09

1.6

1.7

373.20

502.40

pmol/l

—

(3044889) 12 lead EKG panel

277

1.11

0.08

3.6

3.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

132

0.88

0.07

2.2

3.4

8.50

45.41

ng/l

—

(1761868) Lipid panel - Serum or Plasma

149

1.11

0.06

2.8

2.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

137

0.93

0.02

4.2

3.4

27.46

28.42

u/l

0.14

127

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.04

0.00

1.4

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

117

1.03

0.00

2.4

2.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

106

1.05

0.00

1.9

1.6

—

(1616796) Gas panel - Central venous blood

0.00

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.0

2.5

—

10.03

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

1.8

—

57.67

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

0.0

1.2

—

23.53

—

(3011648) Oxygen content in Venous blood

0.00

0.0

1.7

—

10.82

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.0

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.0

2.5

—

4.82

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.7

—

(3028433) Virus identified in Specimen by Culture

0.00

0.0

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

1.8

—

4.19

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

0.0

1.8

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.3

—

13.57

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.7

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

1.7

—

72.33

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

108.00

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

-0.00

0.0

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

3.1

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

5.6

—

27.96

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3021788) Differential panel - Synovial fluid

0.00

-0.00

0.0

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.00

-0.00

0.0

1.0

—

8.68

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.90

-0.00

3.6

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

3.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

3.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

-0.00

0.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

3.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

3.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.0

—

(40768800) Prostate Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.00

-0.00

2.3

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.0

—

(3044941) Cell count panel - Synovial fluid

0.00

-0.00

0.0

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.6

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

2.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

3.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

208.50

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

-0.00

0.0

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

-0.00

0.0

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

-0.00

0.0

2.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

120

1.00

-0.00

2.0

2.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

-0.00

0.0

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

-0.00

0.0

1.4

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_SOLURTICARIA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_SOLURTICARIA.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_SOLURTICARIA – Solar urticaria

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Solar urticaria

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints